Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 12, 2009, Pages 2566-2577

  Bellance, N ^a,b   Benard, G ^a,b   Furt, F ^b,c   Begueret, H ^d   Smolkova K ^a,b,e   Passerieux, E ^a,b   Delage, J P ^a,b   Baste, J M ^d   Moreau, P ^b,c   Rossignol, R ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c University Victor Segalen   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Bioenergetics; Lung tumors; Mitochondria; Oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BCL 2; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RESVERATROL;

ARTICLE; BIOENERGY; BIOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CELL DEATH; CELL METABOLISM; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FETUS; FETUS LUNG; GLYCOLYSIS; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID COMPOSITION; LUNG ADENOCARCINOMA; LUNG FIBROBLAST; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MALE; MITOCHONDRIAL RESPIRATION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 70350641018     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.08.012     Document Type: Article

References (64)

1. Ardail D., Gasnier F., Lerme F., Simonot C., Louisot P., and Gateau-Roesch O. Involvement of mitochondrial contact sites in the subcellular compartmentalization of phospholipid biosynthetic enzymes. J Biol Chem 268 (1993) 25985-25992
2. Arismendi-Morillo G. Electron microscopy morphology of the mitochondrial network in human cancer. Internat J Biochem Cell Biol (2009) 2062-2068
3. Arismendi-Morillo G.J., and Castellano-Ramirez A.V. Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies. J Electron Microsc (Tokyo) 57 (2008) 33-39
4. Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224 (2007) 274-283
5. Bellance N., Lestienne P., and Rossignol R. Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci (2009) 4015-4034
6. Benard G., Bellance N., James D., Parrone P., Fernandez H., Letellier T., et al. Mitochondrial bioenergetics and structural network organization. J Cell Sci 120 (2007) 838-848
7. Benard G., Faustin B., Passerieux E., Galinier A., Rocher C., Bellance N., et al. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 291 (2006) C1172-C1182
8. Benard G., and Rossignol R. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 10 (2008) 1313-1342
9. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
10. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24 (1985) 119-124
11. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
12. Chatterjee A., Mambo E., and Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 25 (2006) 4663-4674
13. Chen Z.X., and Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ 14 (2007) 1617-1627
14. Chretien D., Pourrier M., Bourgeron T., Sene M., Rotig A., Munnich A., et al. An improved spectrophotometric assay of pyruvate dehydrogenase in lactate dehydrogenase contaminated mitochondrial preparations from human skeletal muscle. Clin Chim Acta 240 (1995) 129-136
15. Costello L.C., and Franklin R.B. Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution!. Mol Cancer 5 (2006) 59
16. Cuezva J.M., Krajewska M., de Heredia M.L., Krajewski S., Santamaria G., Kim H., et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62 (2002) 6674-6681
17. de Heredia M.L., Izquierdo J.M., and Cuezva J.M. A conserved mechanism for controlling the translation of beta-F1-ATPase mRNA between the fetal liver and cancer cells. J Biol Chem 275 (2000) 7430-7437
18. Delaval E., Razanoelina M., Bastin J., Freund N., Bismuth J., and Geloso J.P. Mitochondrial activity of rat kidney during ontogeny. J Dev Physiol 14 (1990) 1-5
19. Diaz-Ruiz R., Averet N., Araiza D., Pinson B., Uribe-Carjaval S., Devin A., et al. Mitochondrial oxidative phosphorylation is regulated by fructose-1,6-biphosphate: a possible role in crabtree effect induction?. J Biol Chem (2008)
20. Ding X.Z., and Adrian T.E. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 25 (2002) e71-76
21. Donnely M., and Scheffler I. Energy metabolism in respiration deficient and wild type chinese hamster fibroblasts in culture. J. cell. Physiol 89 (1976) 39-52
22. Freneaux P., Stoppa-Lyonnet D., Mouret E., Kambouchner M., Nicolas A., Zafrani B., et al. Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer 83 (2000) 1318-1322
23. Gatenby R.A., and Gawlinski E.T. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63 (2003) 3847-3854
24. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 4 (2004) 891-899
25. Gstraunthaler G., Seppi T., and Pfaller W. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?. Cell Physiol Biochem 9 (1999) 150-172
26. Guppy M., Leedman P., Zu X., and Russell V. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364 (2002) 309-315
27. Hahn P., and Skala J. Development of enzyme systems. Clin Obstet Gynecol 14 (1971) 655-668
28. Hara M.R., and Snyder S.H. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cell Mol Neurobiol 26 (2006) 527-538
29. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8 (2005) 311-321
30. Hervouet E., Cizkova A., Demont J., Vojtiskova A., Pecina P., Franssen-van Hal N.L., et al. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 29 (2008) 1528-1537
31. Hutter E., Renner K., Pfister G., Stockl P., Jansen-Durr P., and Gnaiger E. Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380 (2004) 919-928
32. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320 (2008) 661-664
33. Isidoro A., Martinez M., Fernandez P.L., Ortega A.D., Santamaria G., Chamorro M., et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J 378 (2004) 17-20
34. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
35. Kamel R., and Schwarzfischer F. Pyruvate kinase isozyme patterns of human neoplastic, fetal and adult tissues. Humangenetik 28 (1975) 65-69
36. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3 (2006) 177-185
37. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (2006) 1109-1122
38. Macala L.J., Yu R.K., and Ando S. Analysis of brain lipids by high performance thin-layer chromatography and densitometry. J Lipid Res 24 (1983) 1243-1250
39. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., and Saavedra E. Energy metabolism in tumor cells. Febs J 274 (2007) 1393-1418
40. Nakai A., Taniuchi Y., Asakura H., Oya A., Yokota A., Koshino T., et al. Developmental changes in mitochondrial activity and energy metabolism in fetal and neonatal rat brain. Brain Res Dev Brain Res 121 (2000) 67-72
41. Nakashima R., Paggi M., and Pedersen P. Contributions of glycolysis and oxidative phosphorylation to adenosine 5′-triphosphate production in AS-30D hepatoma cells. Cancer Res 44 (1984) 5702-5706
42. Passerieux E., Rossignol R., Letellier T., and Delage J.P. Physical continuity of the perimysium from myofibers to tendons: involvement in lateral force transmission in skeletal muscle. J Struct Biol 159 (2007) 19-28
43. Pedersen P. Tumor mitochondria and the bioenergetic of cancer cells. In: Karger S. (Ed). Progress in experimental tumor research (1978), Basel, New York 190-274
44. Pedersen P.L. Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39 (2007) 211-222
45. Pervaiz S., Holme A.L., and Resveratrol:. Its biological targets and functional activity. Antioxid Redox Signal (2009)
46. Reitzer L., Wice B., and Kennel D. Evidence that glutamine, not sugar, is the major energy source for cultured Hela cells. JBC 254 (1979) 2669-2676
47. Rossignol R., Gilkerson R., Aggeler R., Yamagata K., Remington S.J., and Capaldi R.A. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64 (2004) 985-993
48. Rossignol R., Letellier T., Malgat M., Rocher C., and Mazat J.P. Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases. Biochem J 347 Pt 1 (2000) 45-53
49. Saunders P.A., Chen R.W., and Chuang D.M. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J Neurochem 72 (1999) 925-932
50. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., et al. Identification of cells initiating human melanomas. Nature 451 (2008) 345-349
51. Shaw R.J. Glucose metabolism and cancer. Curr Opin Cell Biol 18 (2006) 598-608
52. Simonnet H., Alazard N., Pfeiffer K., Gallou C., Beroud C., Demont J., et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23 (2002) 759-768
53. Simonnet H., Demont J., Pfeiffer K., Guenaneche L., Bouvier R., Brandt U., et al. Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis 24 (2003) 1461-1466
54. Trounce I.A., Kim Y.L., Jun A.S., and Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264 (1996) 484-509
55. Uriel J. Cancer, retrodifferentiation, and the myth of Faust. Cancer Res 36 (1976) 4269-4275
56. Ventura-Clapier R., Garnier A., and Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha}. Cardiovasc Res 79 (2008) 208-217
57. Vincent A.S., Phan T.T., Mukhopadhyay A., Lim H.Y., Halliwell B., and Wong K.P. Human skin keloid fibroblasts display bioenergetics of cancer cells. J Invest Dermatol 128 (2008) 702-709
58. Vitiello F., and Zanetta J.P. Thin-layer chromatography of phospholipids. J Chromatogr 166 (1978) 637-640
59. Warburg. Metabolism of tumors (1930), Arnold Constable, London
60. Watkins G., Douglas-Jones A., Mansel R.E., and Jiang W.G. The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer. Oncol Rep 12 (2004) 483-488
61. Weinhouse S. Isozyme alterations, gene regulation and the neoplastic transformation. Adv Enzyme Regul 21 (1983) 369-386
62. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., and Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009) 1076-1080
63. Wu M., Neilson A., Swift A.L., Moran R., Tamagnine J., Parslow D., et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292 (2007) C125-C136
64. Zu X.L., and Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313 (2004) 459-465